tiprankstipranks
Trending News
More News >
Kringle Pharma, Inc. (JP:4884)
:4884
Japanese Market

Kringle Pharma, Inc. (4884) Income Statement

Compare
0 Followers

Kringle Pharma, Inc. Income Statement

Last quarter (Q3 2025), Kringle Pharma, Inc.'s total revenue was ¥17.96M, a decrease of -2.71% from the same quarter last year. In Q3, Kringle Pharma, Inc.'s net income was ¥-226.99M. See Kringle Pharma, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
¥ 72.22M¥ 80.04M¥ 69.25M¥ 391.83M¥ 289.76M
Gross Profit
¥ 0.00¥ 80.04M¥ 69.25M¥ 303.42M¥ 218.16M
Operating Expenses
¥ 981.67M¥ 897.92M¥ 958.01M¥ 729.58M¥ 576.04M
Depreciation and Amortization
¥ 0.00¥ 817.00M¥ 0.00¥ 0.00¥ -1.00K
EBITDA
¥ -914.76M¥ -817.88M¥ -888.76M¥ -426.17M¥ -357.88M
Operating Income
¥ -909.45M¥ -817.88M¥ -888.76M¥ -426.17M¥ -357.88M
Other Income/Expenses
¥ -5.30M¥ 62.92M¥ 36.10M¥ 95.83M¥ 58.20M
Pretax Income
¥ -914.75M¥ -754.96M¥ -852.66M¥ -330.34M¥ -299.68M
Net Income
¥ -916.25M¥ -756.45M¥ -854.15M¥ -331.83M¥ -301.17M
Per Share Metrics
Basic EPS
¥ -133.92¥ -118.21¥ -158.46¥ -68.33¥ -72.51
Diluted EPS
¥ -133.92¥ -118.21¥ -158.46¥ -68.33¥ -72.51
Weighted Average Shares Outstanding
6.84M 6.40M 5.39M 4.86M 4.15M
Weighted Average Shares Outstanding (Diluted)
6.84M 6.40M 5.39M 4.86M 4.15M
Currency in JPY

Kringle Pharma, Inc. Earnings and Revenue History